Details for New Drug Application (NDA): 040359
✉ Email this page to a colleague
The generic ingredient in ESTROPIPATE is estropipate. There are two drug master file entries for this compound. Additional details are available on the estropipate profile page.
Summary for 040359
Tradename: | ESTROPIPATE |
Applicant: | Mylan |
Ingredient: | estropipate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.75MG | ||||
Approval Date: | Aug 26, 1999 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 1.5MG | ||||
Approval Date: | Aug 26, 1999 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 3MG | ||||
Approval Date: | Aug 26, 1999 | TE: | RLD: | No |
Complete Access Available with Subscription